Should you get the COVID-19 vaccine if you’re pregnant? 5 key things to know
News 12 Staff
Updated on:Jan 27, 2021, 6:13am EST
As the COVID-19 vaccine rolls out to the general population, many pregnant women are wondering if they should get the vaccine.
Here are some key things you should know about the vaccine if you’re pregnant:
1. Should the vaccine be withheld from pregnant women?
Vaccination is likely the best way to prevent COVID-19 in pregnancy, when risks for severe illness and death from the virus are higher than usual.
The American College of Obstetricians and Gynecologists says COVID-19 vaccinations should not be withheld from pregnant women, and that women should discuss individual risks and benefits with their health care providers.
Tags »
ATLANTA – The American Heart Association (AHA) and The Mitral Foundation have designated Emory Saint Joseph’s Hospital as a Mitral Valve Repair Reference Center, a recognition awarded to hospitals that have shown excellence in clinical outcomes and performance in mitral valve repairs.
Emory Saint Joseph’s Hospital is the first hospital in the southeast to receive the designation. This is a well-deserved recognition from The Mitral Foundation and the American Heart Association. We have developed highly specialized teams to provide the best care possible to patients with mitral valve disease, says Michael Halkos, MD, professor of surgery at Emory University School of Medicine and chief of cardiothoracic surgery at Emory Healthcare, which operates one of the largest cardiothoracic (CT) surgery programs in the country and the largest in Georgia. Emory Saint Joseph’s has long been recognized as a premier mitral valve repair center with one of the highest volume and b
The American College of Physicians (ACP) and
Annals of Internal Medicine hosted a third virtual COVID-19 vaccine forum on COVID-19 with the focus on the allocation and distribution of available vaccines, a topic that has created controversy as the nation works to get millions of Americans vaccinated.
The forum, Allocation and Distribution: What Physicians Need to Know, was the third in a series of vaccine forums hosted by ACP and
Annals of Internal Medicine and was held on Jan. 22. ACP and
Annals of Internal Medicine invited four experts to offer their perspectives on vaccine allocation and distribution. Panelists included Capt. Amanda Cohn, Chief Medical Officer of the National Center for Immunizations and Respiratory Diseases (NCIRD) and Executive Secretary of the Advisory Committee on Immunization Practices; David Fairchild, MD, MPH, Chief Medical Officer, CVS MinuteClinic, Professor of Medicine, University of Massachusetts Medical School; Wayne J. Riley, MD, MPH, MBA, MAC
How ICMR and Others Spun Covaxin s Phase 1 Trial Results Out of Context
Even though ICMR chief Balram Bhargava is one of the paper s authors, he has attempted to hype up its results.
A medic fills a syringe with Covaxin in Ahmedabad, November 26, 2020. Photo: Reuters/Amit Dave
A paper published in
The Lancet on January 21, 2021, describes the results of Covaxin’s phase 1 clinical trial. Much of its contents were known already â but as disinformation campaigns go, this one takes the biscuit.
On January 23, the
Times of Indiapublished a story under the headline, “Amid efficacy row, Covaxin gets a thumbs up from Lancet”.